Abstract
Brain iron overload has a key role in brain injury after intracerebral hemorrhage (ICH). Low aerobic capacity is a risk factor for cardiovascular disease and our previous study demonstrated that ICH-induced brain injury is enhanced in rats with low aerobic capacity (low capacity runners; LCRs). We have found that ICH-induced injury is less in female rats compared with that in males. In the present study, we examined the effects of gender on iron-induced brain injury in rats with low aerobic capacity. Adult male and female LCR rats had an intracaudate injection of FeCl2 (50 μl 0.5 mM). T2 Magnetic resonance imaging was carried out at 24 h to determine brain swelling and T2 brain lesion volume. Albumin leakage, an indicator of blood-brain barrier (BBB) disruption, and heme oxygenase-1 (HO-1, a stress marker) levels were determined. Male LCR rats had more severe hemisphere swelling (difference of ipsilateral to contralateral hemisphere volume: 16.6 ± 4.1 vs 11.1 ± 2.6 % in females, p < 0.05) and larger T2 lesion volumes (120 ± 28 vs 87 ± 27 mm3 in females, p < 0.05) after iron injection. Iron also resulted in more severe BBB disruption in the ipsilateral hemisphere of males (albumin levels: 7,717 ± 1,502 pixels in males vs 5,287 ± 1,342 pixels in females; p < 0.05). The immunoreactivity of HO-1 was also significantly higher in males than females (HO-1/β-actin: 1.31 ± 0.44 vs 1.03 ± 0.05, p < 0.05). Female LCR rats had less iron-induced brain swelling, smaller lesion volumes, and reduced BBB disruption and HO-1 upregulation compared with male LCR rats. This may contribute to the reduced ICH-induced brain injury found in females.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
Introduction
Spontaneous intracerebral hemorrhage (ICH) is a common and often fatal stroke subtype [14]. Iron has a major role in brain damage following ICH [17, 20, 22]. We have shown a significant increase in brain non-heme iron after ICH in rats, and this remains high for at least 1 month [19]. Brain iron overload causes brain edema in the acute phase and brain atrophy later after ICH, with an iron chelator, deferoxamine, reducing ICH-induced brain edema, neuronal death, brain atrophy, and neurological deficits in young rats [5, 10, 16], aged rats [12, 13], and pigs [2]. Recent studies show that high levels of serum ferritin, an iron storage protein, are independently associated with poor outcome and severe brain edema in ICH patients [8, 15].
Our previous study showed that females have less brain edema and a faster recovery of behavioral deficits after ICH and 17β-estradiol treatment markedly reduced ICH-induced brain injury [1, 9, 11]. Estrogen pretreatment attenuated iron-induced brain edema and neuronal death [3, 7]. We have shown in a model that low aerobic capacity (low capacity runner rats; LCRs) had more severe ICH-induced brain injury than high capacity runners, including worse brain edema, brain atrophy, and neurological deficits, and that females were protected against ICH-induced brain edema formation in both high capacity runners and LCRs [4].
The present study examines whether gender-specific differences in iron-induced brain injury in LCR rats might contribute to the gender differences found in ICH-induced injury.
Materials and Methods
Animal Preparation and Intracerebral Infusion
All animal procedures were approved by the University Committee on Use and Care of Animals, University of Michigan. A detailed description of the development of low aerobic capacity rats has been published previously [18]. Adult male (n = 7) and female LCR rats (n = 6) were anesthetized with pentobarbital (45 mg/kg, intraperitoneally (IP)) and the right femoral artery was catheterized to monitor arterial blood pressure, blood pH, PaO2, PaCO2, hematocrit, and glucose levels. Body temperature was maintained at 37.5 °C by a feedback-controlled heating pad. A polyethylene catheter (PE-50) was inserted into the right femoral artery to monitor arterial blood pressure and blood gases. Animals were then positioned in a stereotactic frame and injections administered into the right basal ganglia (coordinates at 0.2 mm anterior to bregma, 5.5 mm ventral, and 3.5 mm lateral to midline). All the animals had 50 μl FeCl2 (0.5 mM) or saline infused into the right caudate at 5 μl/min using a microinfusion pump. After injection, the needle was removed and the skin incisions closed. T2 magnetic resonance imaging (MRI) was performed at 24 h after iron injection and the rats were then used for brain histology and Western blotting.
Magnetic Resonance Imaging and Volume Measurement
Imaging was carried out in a 7.0-T Varian MR scanner (183-mm horizontal bore; Varian, Palo Alto, CA, USA) at the Center for Molecular Imaging (CMI) of the University of Michigan. Rats were anesthetized with 2 % isoflurane/air mixture throughout MRI examination. The imaging protocol for all rats included a T2 fast spin-echo sequence (TR/TE = 4000/60 ms). The images were preserved as 256 × 256 pixels images; the lesion volumes and hemisphere volumes were measured by a blinded observer with NIH ImageJ [23]. Lesion volume was calculated by multiplying the total lesion area across all sections by the distance between the sections. Brain swelling calculation was based on 7 every other section of which the center was the anterior commissure layer. The value was ((volume of right hemisphere – volume of left hemisphere)/volume of right hemisphere) × 100 %.
Immunohistochemistry
Immunohistochemistry was performed as described previously [6, 21]. Briefly, rats were anesthetized and subjected to intracardiac perfusion with 4 % paraformaldehyde in 0.1 mM phosphate-buffered saline (pH 7.4). Brains were removed and kept in 4 % paraformaldehyde for 6 h, then immersed in 30 % sucrose for 3–4 days at 4 °C. After embedding in a mixture of 30 % sucrose and OCT, 18 μm sections were cut on a cryostat. For immunohistochemistry, the primary antibodies were goat anti-albumin antibody (Bethyl Laboratories, Inc., 1:600 dilution, Montgomery, TX) and rabbit polyclonal HO-1 antibody (1:600 dilution; Assay Designs/Stressgen, Farmingdale, NY).
Western Blot Analysis
Western blot analysis was performed as previously described [21]. Briefly, brain tissue was immersed in Western sample buffer and sonicated. Protein concentration was determined by Bio-Rad protein assay kit, and 50 μg protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a Hybond-C pure nitrocellulose membrane. Membranes were probed with goat anti-albumin antibody (Bethyl Laboratories, Inc., 1:10,000 dilution, Montgomery, TX), and rabbit polyclonal HO-1 antibody (1:2,000 dilution; Assay Designs/Stressgen, Farmingdale, NY). The antigen–antibody complexes were visualized with the ECL chemiluminescence system and exposed to Kodak X-OMAT film. The relative densities of bands were analyzed with NIH ImageJ.
Statistical Analysis
All the data in this study are presented as mean ± standard deviation (SD). Data were analyzed by Student’s t-test or analysis of variance (ANOVA). Differences were considered significant at p < 0.05.
Results
The LCR rats used in this study were from generation 29–33 of the breeding program. All physiological parameters were monitored during intracerebral infusions. No rats died postoperatively.
T2 lesion volumes at 24 h after iron infusion were larger in males (120 ± 28 mm3) than in females (87 ± 27 mm3, p < 0.05); Fig. 1a, b). There was also more severe brain swelling in males (16.6 ± 4.1 %) compared with females (11.1 ± 2.6 %, p < 0.05; Fig. 1a, c).
Albumin is normally excluded from the brain by the blood-brain barrier (BBB), and entry of albumin is a marker of BBB disruption. Intracaudate FeCl2 injection caused marked BBB disruption in the ipsilateral hemisphere 24 h after injection (Fig. 2) with much higher albumin protein levels in the ipsilateral basal ganglia than in the contralateral (p < 0.01, Fig. 2). The albumin-positive area was larger in the ipsilateral hemisphere in males than females (Fig. 2) and albumin protein levels (Western blot) were significantly higher in males (7,717 ± 1,502 vs 5,287 ± 1,342 pixels in females, p < 0.05; Fig. 2).
HO-1 is a marker for brain stress that is expressed at very low levels in normal brain. The number of cells immunoreactive for HO-1 at 24 h after FeCl2 injection was greater in male than female LCR rats (Fig. 3). Similarly, as assessed by Western blot, HO-1 protein levels in the ipsilateral basal ganglia were higher in males than females (HO-1/β-actin: 1.31 ± 0.44 vs 1.03 ± 0.05, p < 0.05; Fig. 3).
Discussion
In the present study, we found that male rats had comparatively more severe hemispheric swelling, BBB disruption, and larger T2 lesions after intracerebral iron injection into the caudate. In addition, iron induced much stronger expression of HO-1 in males than females.
Brain iron overload has an important role in ICH-induced brain injury. The current results suggest that differences in iron-mediated damage contribute to gender differences in ICH-induced brain injury. It is still unknown why iron-induced brain swelling is less in female LCRs. For iron-induced brain injury, most research has focused on oxidative injury. The reduction in the iron-induced upregulation of brain HO-1 expression (a cellular stress marker) in females may reflect reduced oxidative stress. This needs investigation.
Iron-induced brain edema could be vasogenic and cytotoxic. Our results showed that BBB leakage was more severe in males than females, suggesting less vasogenic brain edema in females. We have previously shown that females have less severe ICH-induced brain injury than males through an estrogen receptor-dependent mechanism [9]. More experiments are needed to determine whether estrogen and its receptors have a role in ameliorating iron-induced BBB disruption and vasogenic brain edema.
In conclusion, iron caused less brain damage, BBB leakage, and brain swelling in female LCRs compared with males. Gender differences in iron-induced injury may contribute to differences between females and males in ICH-induced brain injury.
References
Davis CM, Fairbanks SL, Alkayed NJ (2013) Mechanism of the sex difference in endothelial dysfunction after stroke. Transl Stroke Res 4:381–389
Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G (2009) Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke 40:2241–2243
Gu Y, Xi G, Liu W, Keep RF, Hua Y (2010) Estrogen reduces iron-mediated brain edema and neuronal death. Acta Neurochir Suppl 106:159–162
He Y, Liu W, Koch LG, Britton SL, Keep RF, Xi G, Hua Y (2012) Susceptibility to intracerebral hemorrhage-induced brain injury segregates with low aerobic capacity in rats. Neurobiol Dis 49C:22–28
Hua Y, Nakamura T, Keep R, Wu J, Schallert T, Hoff J, Xi G (2006) Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 104:305–312
Jin H, Xi G, Keep RF, Wu J, Hua Y (2013) DARPP-32 to quantify intracerebral hemorrhage-induced neuronal death in basal Ganglia. Transl Stroke Res 4:130–134
Koellhoffer EC, McCullough LD (2013) The effects of estrogen in ischemic stroke. Transl Stroke Res 4:390–401
Mehdiratta M, Kumar S, Hackney D, Schlaug G, Selim M (2008) Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage. Stroke J Cereb Circ 39:1165–1170
Nakamura T, Hua Y, Keep RF, Park JW, Xi G, Hoff JT (2005) Estrogen therapy for experimental intracerebral hemorrhage in rats. J Neurosurg 103:97–103
Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G (2004) Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100:672–678
Nakamura T, Xi G, Hua Y, Schallert T, Hoff JT, Keep RF (2004) Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. J Cereb Blood Flow Metab 24:487–494
Okauchi M, Hua Y, Keep RF, Morgenstern LB, Schallert T, Xi G (2010) Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke 41:375–382
Okauchi M, Hua Y, Keep RF, Morgenstern LB, Xi G (2009) Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke 40:1858–1863
Pandey AS, Xi G (2014) Intracerebral hemorrhage: a multimodality approach to improving outcome. Transl Stroke Res 5:313–315
Perez de la Ossa N, Sobrino T, Silva Y, Blanco M, Millan M, Gomis M, Agulla J, Araya P, Reverte S, Serena J, Davalos A (2010) Iron-related brain damage in patients with intracerebral hemorrhage. Stroke J Cereb Circ 41:810–813
Song S, Hua Y, Keep RF, Hoff JT, Xi G (2007) A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke 38:2861–2863
Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF (2003) Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab 23:629–652
Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q, Fernstrom M, Rezaei K, Lee SJ, Koch LG, Britton SL (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307:418–420
Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G (2003) Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34:2964–2969
Xi G, Keep RF, Hoff JT (2006) Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 5:53–63
Xi G, Keep RF, Hua Y, Xiang JM, Hoff JT (1999) Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30:1247–1255
Xiong XY, Wang J, Qian ZM, Yang QW (2014) Iron and intracerebral hemorrhage: from mechanism to translation. Transl Stroke Res 5:429–441
Zhao J, Chen Z, Xi G, Keep RF, Hua Y (2014) Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats. Transl Stroke Res 5:586–594
Acknowledgments
This study was supported by grants NS-073959, NS079157, and NS-084049 from the National Institutes of Health (NIH) and 973 Program-2014CB541600. The LCR-HCR rat model system was funded by the Office of Research Infrastructure Programs/OD grant R24OD010950 and by grant R01DK099034 (to LGK and SLB) from the National Institutes of Health. SLB was also supported by National Institutes of Health grants R01DK077200 and R01GM104194. We acknowledge the expert care of the rat colony provided by Molly Kalahar and Lori Heckenkamp. Contact LGK (lgkoch@med.umich.edu) or SLB (brittons@umich.edu) for information on the LCR and HCR rats: these rat models are maintained as an international resource with support from the Department of Anesthesiology at the University of Michigan, Ann Arbor, Michigan.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Zheng, M. et al. (2016). Effect of Gender on Iron-induced Brain Injury in Low Aerobic Capacity Rats. In: Applegate, R., Chen, G., Feng, H., Zhang, J. (eds) Brain Edema XVI. Acta Neurochirurgica Supplement, vol 121. Springer, Cham. https://doi.org/10.1007/978-3-319-18497-5_63
Download citation
DOI: https://doi.org/10.1007/978-3-319-18497-5_63
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18496-8
Online ISBN: 978-3-319-18497-5
eBook Packages: MedicineMedicine (R0)